"17848. Adulteration and Misbranding of antipyrine tablets, barbital tab- 
lets, calomel tablets, mercuric iodide tablets, santonin and calo- 
mel tablets, sodium sulphocarbolate tablets, strycbnine snlpbate 
tablets, sulphonal tablets, trional tablets, and nitroglycerin, tab- 
lets. 17. S. v. George A. Breon ?fc Co. Plea of nolo contendere. 
Fine, $1,000 and costs. (F. & D. No. 25011. I. S. Nos. 011378, 011379, 
011382, 011384, 011386, 011390, 011392, 011393, 011394, 011403.)
Examination of various drugs in tablet form from the interstate shipments 
described herein showed that the said tablets contained a smaller quantity of 
the principal therapeutic agent than represented on the label, with the excep- 
tion of the santonin and calomel tablets, in which an excess of the said drugs 
was found.
On June 27, 1930, the United States attorney for the Western District of Mis- 
souri, acting upon a report by the Secretary of Agriculture, filed in the District 
Court of the United States for the district aforesaid an information against 
George A. Breon & Co., a corporation, Kansas City, Mo., alleging shipment by 
said company, in violation of the food and drugs act, on or about June 13, 1929, 
from the State of Missouri into the State of Minnesota, of quantities of anti- 
pyrine tablets, barbital tablets, calomel tablets, mercuric iodide tablets, san- 
tonin and calomel tablets, sodium sulphocarbolate tablets, strychnine sulphate 
tablets, sulphonal tablets, trional tablets, and nitroglycerin tablets, which were 
adulterated and misbranded. The articles were labeled in part as hereinafter 
set forth.
It was alleged in the information that the articles were adulterated in that 
their strength and purity fell below the professed standard and quality under 
which they were sold, as follows: The antipyrine tablets were each represented 
to contain 1 grain of antipyrine, whereas they contained less than so repre- 
sented, namely, not more than 0.796 grain of antipyrine per tablet. The barbital 
tablets were each represented to contain 5 grains of barbital, whereas they 
contained less than so represented, namely, not more than 3.28 grains of barbital 
per tablet. The calomel tablets were each represented to contain one-half grain 
of calomel, whereas they contained less than so represented, namely, not more 
than 0.44 grain of calomel per tablet. The mercuric iodide tablets were each 
represented to contain one-fourth grain of mercuric iodide, whereas they con- 
tained less than so represented, namely, not more than 0.208 grain of mercuric 
iodide per tablet. The santonin and calomel tablets were each represented to 
conta'n one-half grain of santonin and one-half grain of calomel, whereas they 
contained more of the said drugs than so represented, namely, not less than
'0.586 grain of santonin and not less than 0.572 grain of calomel per tablet. The 
sodium sulphocarbolate tablets were each represented to contain 5 grains of 
sodium sulphocarbolate, whereas they contained less than so represented, 
namely, not more than 4.125 grains of sodium sulphocarbolate per tablet. The 
strychnine sulphate tablets were each represented to contain 1/40 grain of 
strychnine sulphate, whereas they contained less than so represented, namely, 
not more than 0.0193 grain of strychnine sulphate per tablet. The sulphonal 
tablets were each represented to contain 5 grains of sulphonal (sulphon 
methane), whereas they contained less than so represented, namely, not more 
than 1.581 grains of sulphonal (sulphone methane) per tablet. The trional 
tablets were each represented to contain 5 grains of trional (sulphon ethyl 
methane), whereas they contained less than so represented, namely, not more 
than 4.29 grains of trional (sulphon ethyl methane) per tablet. The nitro- 
glycerin tablets were represented to contain 1/100 grain of nitroglycerin, whereas 
they contained less than so represented, namely, not more than 0.00088 grain 
(less than 1/1000 of a grain) of nitroglycerin per tablet.
Misbranding was alleged for the reason that the statements, to wit, " Tablets 
Antipyrine 1 grains," " Tablets Barbital Diethyl-Barbituric Acid * * * 5 
?Gr.," " Tablets Calomel 1/2 grains," " Tablets Mercuric Iodide, Red 1/4 grains," 
?" Tablets Santonin and Calomel Santonin 1-2 gr. Calomel 1-2 gr.," "Tablets 
Sodium Sulphocarbolate 5 grs.," "Tablets Strychnine Sulphate 1-40 grain," 
"Tablets Sulphonal (Sulphon Methane) 5 grs.," "Tablets Trional (Sulphon 
Ethyl Methane) 5 grs.," and " Nitroglycerin 1/100 gr.," borne on the labels of 
the respective products, were false and misleading in that the said statements 
represented that the articles contained the amount of the drug declared on the 
label, whereas they contained less than represented, with the exception of the 
santonin and calomel tablets, in which case they contained more santonin and 
?calomel than represented.
On December 13, 1930, a plea of nolo contendere to the information was en- 
tered on behalf of the defendant company, and the court imposed a fine of 
.$1,000 and costs.
ARTHUR M. HYDE, Secretary of Agriculture.